BIOMAT Database Logo BIOMAT Database Logo

Cefotaxime for treatment of gram-negative bacterial meningitis in infants and children. 1987

T J Feldstein, and D L Uden, and T A Larson

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

T J Feldstein, and D L Uden, and T A Larson
Cefotaxime treatment of gram-negative enteric meningitis in infants and children.
January 1988, Drugs,
T J Feldstein, and D L Uden, and T A Larson
Treatment of Gram negative meningitis with cefotaxime.
July 1983, Neurochirurgia,
T J Feldstein, and D L Uden, and T A Larson
[Value of cefotaxime in gram-negative bacterial meningitis. Apropos of 3 developmental forms in neonates and infants].
December 1984, Pediatrie,
T J Feldstein, and D L Uden, and T A Larson
Effectiveness of cefotaxime in gram-negative meningitis.
November 1984, Neurosurgery,
T J Feldstein, and D L Uden, and T A Larson
Treatment of gram-negative bacterial meningitis.
September 1987, The Western journal of medicine,
T J Feldstein, and D L Uden, and T A Larson
Cefotaxime vs. conventional therapy for the treatment of bacterial meningitis of infants and children.
January 1986, Pediatric infectious disease,
T J Feldstein, and D L Uden, and T A Larson
Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children.
April 1995, Antimicrobial agents and chemotherapy,
T J Feldstein, and D L Uden, and T A Larson
Ampicillin-cefotaxime for initial treatment of bacterial meningitis in children.
May 1985, Canadian Medical Association journal,
T J Feldstein, and D L Uden, and T A Larson
Cefotaxime therapy of neonatal gram-negative bacillary meningitis.
January 1985, Pediatric infectious disease,
T J Feldstein, and D L Uden, and T A Larson
Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms.
November 1990, The Pediatric infectious disease journal,
Copied contents to your clipboard!